BVNRY BAVARIAN NORDIC
$11.04
BAVARIAN NORDIC (BVNRY) is expected to report earnings on November 20, 2026, before the market open.
BAVARIAN NORDIC Reported Earnings
Friday, August 21, 2026 · 12:00 AM ET
Earnings Date
Nov 20
Friday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
-
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About BAVARIAN NORDIC
Bavarian Nordic A/S is a biotechnology company. It focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company's product pipeline consists of IMVAMUNE(R), PROSTVAC (R), MVA-BN Brachyury, CV-301, MVA-BN Filo which are in clinical trial stage. Bavarian Nordic A/S is headquartered in Kvistgaard, Denmark.
Sector
Healthcare
Charts powered in part by Lightweight Charts™ by TradingView.